COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds

Beeke Tappe, Chris D. Lauruschkat, Lea Strobel, Jezreel Pantaleón García, Oliver Kurzai, Silke Rebhan, Sabrina Kraus, Elena Pfeuffer-Jovic, Lydia Bussemer, Lotte Possler, Matthias Held, Kerstin Hünniger, Olaf Kniemeyer, Sascha Schäuble, Axel A. Brakhage, Gianni Panagiotou, P. Lewis White, Hermann Einsele, Jürgen Löffler, Sebastian Wurster

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Patients suffering from coronavirus disease-2019 (COVID-19) are susceptible to deadly secondary fungal infections such as COVID-19-associated pulmonary aspergillosis and COVID-19-associated mucormycosis. Despite this clinical observation, direct experimental evidence for severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)-driven alterations of antifungal immunity is scarce. Using an ex-vivo whole blood stimulation assay, we challenged blood from twelve COVID-19 patients with Aspergillus fumigatus and Rhizopus arrhizus antigens and studied the expression of activation, maturation, and exhaustion markers, as well as cytokine secretion. Compared to healthy controls, T-helper cells from COVID-19 patients displayed increased expression levels of the exhaustion marker PD-1 and weakened A. fumigatus- and R. arrhizus-induced activation. While baseline secretion of proinflammatory cytokines was massively elevated, whole blood from COVID-19 patients elicited diminished release of T-cellular (e.g., IFN-γ, IL-2) and innate immune cell-derived (e.g., CXCL9, CXCL10) cytokines in response to A. fumigatus and R. arrhizus antigens. Additionally, samples from COVID-19 patients showed deficient granulocyte activation by mold antigens and reduced fungal killing capacity of neutrophils. These features of weakened anti-mold immune responses were largely decoupled from COVID-19 severity, the time elapsed since diagnosis of COVID-19, and recent corticosteroid uptake, suggesting that impaired anti-mold defense is a common denominator of the underlying SARS-CoV-2 infection. Taken together, these results expand our understanding of the immune predisposition to post-viral mold infections and could inform future studies of immunotherapeutic strategies to prevent and treat fungal superinfections in COVID-19 patients.

Original languageEnglish (US)
Article number954985
JournalFrontiers in immunology
Volume13
DOIs
StatePublished - Aug 16 2022

Keywords

  • Aspergillus
  • COVID-19
  • granulocytes
  • immune impairment
  • Rhizopus
  • T cells

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds'. Together they form a unique fingerprint.

Cite this